OGN - Organon & Co logo

Organon & Co

OGN

Organon & Co. develops women's health solutions through prescription therapies and medical devices, offering contraceptives, fertility treatments, and products for various medical conditions, including respiratory and cardiovascular issues, to healthcare providers globally.

โš•๏ธ Healthcare NYSE Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$501today

Score Overview

1 Year
Score
Net Growth11.76%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-1.43%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score3.9
Net Growth-84.53%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-2.81%
Rev Trend40%
Revenue Consistencyโ€”
All Time
Score
Net Growth-84.53%
Net Trend40%
Net Income Consistency
Rev Growth-2.81%
Rev Trend40%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Organon & Co has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 5 years of fundamentals. OGN does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-01
$ 13.71โ€”
1 Year2025-10-01
$ 10.9025.77%
5 Years2021-10-01
$ 27.35-49.87%
All Time2021-06-02
$ 28.69-52.22%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 6.12B$ 209M$ 1.13B
2025$ 6.21B$ 187M$ 574M
2024$ 6.40B$ 864M$ 675M
2023$ 6.26B$ 1.02B$ 693M
2022$ 6.17B$ 917M$ 706M
IPO2021$ 6.30B$ 1.35B$ 737M
OGN - Organon & Co logo

Organon & Co fundamental performance

Across Organon & Co's full reported history, from 2021 to 2025, revenue declined from $ 6.30B to $ 6.21B and net income declined from $ 1.35B to $ 187M. Revenue increased in 40% of the years measured; net income in 40%.

Organon & Co currently holds a 5-year HDB Score of 3.9 out of 10. How the HDB Score is calculated.

Membership

Explore OGN with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,813 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies